Showing results (231-240 of 263) with videos related to
Sort By:
Pageof 27
Oncoimmunology|July 21, 2022
Synergistic antitumor response with recombinant modified virus Ankara armed with CD40L and CD137L against peritoneal carcinomatosisÁngela Bella, Leire Arrizabalaga, Claudia Augusta Di Trani, et al.Iscience|August 23, 2023
Inhalation of ACE2 as a therapeutic target on sex-bias differences in SARS-CoV-2 infection and variant of concernYu Onodera, Jady Liang, Yuchong Li, et al.The EMBO Journal|August 10, 2021
Identification of lectin receptors for conserved SARS-CoV-2 glycosylation sitesDavid Hoffmann, Stefan Mereiter, Yoo Jin Oh, et al.Journal for Immunotherapy of Cancer|November 2, 2023
Intraperitoneal administration of a modified vaccinia virus Ankara confers single-chain interleukin-12 expression to the omentum and achieves immune-mediated efficacy against peritoneal carcinomatosisÁngela Bella, Leire Arrizabalaga, Claudia Augusta Di Trani, et al.Frontiers in Immunology|October 4, 2023
Comparative transcriptomic and proteomic signature of lung alveolar macrophages reveals the integrin CD11b as a regulatory hub during pneumococcal pneumonia infectionKristina Zec, Stephanie Thiebes, Jenny Bottek, et al.The Journal of Clinical Investigation|October 11, 2016
Matricellular protein SPARCL1 regulates tumor microenvironment-dependent endothelial cell heterogeneity in colorectal carcinomaElisabeth Naschberger, Andrea Liebl, Vera S Schellerer, et al.Nature|July 20, 2018
Thymic tuft cells promote an IL-4-enriched medulla and shape thymocyte developmentCorey N Miller, Irina Proekt, Jakob von Moltke, et al.Gut Pathogens|June 1, 2017
Comparison of clinical and immunological findings in gnotobiotic piglets infected with Escherichia coli O104:H4 outbreak strain and EHEC O157:H7Bettina Wöchtl, Florian Gunzer, Wilhelm Gerner, et al.Langenbeck'S Archives of Surgery|January 23, 2009
Malignant fibrous histiocytoma--pleomorphic sarcoma, NOS gene expression, histology, and clinical course. A pilot studyAdrien Daigeler, Daigeler Adrien, Ludger Klein-Hitpass, et al.Cell Reports|May 11, 2016
The Tumor Suppressor Hace1 Is a Critical Regulator of TNFR1-Mediated Cell FateLuigi Tortola, Roberto Nitsch, Mathieu J M Bertrand, et al.Pageof 27